Log In
Print
BCIQ
Print
Print this Print this
 

DP-4978

  Manage Alerts
Collapse Summary General Information
Company Deciphera Pharmaceuticals LLC
DescriptionOral small molecule dual inhibitor of mutant BRAF and CRAF.
Molecular Target BRAF ; CRAF (RAF1)
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationMelanoma
Partner

Eli Lilly and Co.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today